Shamik Bhattacharyya, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Diseases | 6 | 2024 | 290 | 3.590 |
Why?
|
| Sarcoidosis | 5 | 2024 | 532 | 2.170 |
Why?
|
| Sjogren's Syndrome | 2 | 2021 | 239 | 1.060 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2024 | 2159 | 1.000 |
Why?
|
| Central Nervous System Diseases | 3 | 2020 | 518 | 0.970 |
Why?
|
| Brain Infarction | 2 | 2017 | 285 | 0.880 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2024 | 65 | 0.870 |
Why?
|
| Multiple Sclerosis | 6 | 2024 | 3213 | 0.800 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2023 | 132 | 0.780 |
Why?
|
| Cerebellar Diseases | 1 | 2023 | 226 | 0.750 |
Why?
|
| Arachnoiditis | 1 | 2021 | 9 | 0.740 |
Why?
|
| Neuromyelitis Optica | 2 | 2023 | 266 | 0.740 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2021 | 39 | 0.730 |
Why?
|
| Polyarteritis Nodosa | 1 | 2021 | 68 | 0.730 |
Why?
|
| Myelitis | 1 | 2021 | 49 | 0.730 |
Why?
|
| Enterovirus Infections | 1 | 2021 | 74 | 0.710 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 2226 | 0.710 |
Why?
|
| Behcet Syndrome | 1 | 2021 | 86 | 0.710 |
Why?
|
| Giant Cell Arteritis | 2 | 2021 | 302 | 0.700 |
Why?
|
| Syringomyelia | 1 | 2021 | 66 | 0.700 |
Why?
|
| Arachnoid Cysts | 1 | 2021 | 59 | 0.690 |
Why?
|
| Brain Diseases | 3 | 2019 | 1546 | 0.670 |
Why?
|
| Abscess | 1 | 2023 | 606 | 0.660 |
Why?
|
| Spinal Cord | 4 | 2023 | 1784 | 0.640 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2019 | 32 | 0.640 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2019 | 44 | 0.620 |
Why?
|
| Cerebral Veins | 1 | 2019 | 157 | 0.600 |
Why?
|
| Neurology | 4 | 2024 | 785 | 0.580 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2018 | 74 | 0.580 |
Why?
|
| Spondylosis | 1 | 2018 | 84 | 0.570 |
Why?
|
| Apraxias | 1 | 2017 | 58 | 0.550 |
Why?
|
| Videotape Recording | 1 | 2017 | 331 | 0.500 |
Why?
|
| Connective Tissue Diseases | 1 | 2019 | 284 | 0.500 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2016 | 45 | 0.490 |
Why?
|
| Inosine | 1 | 2016 | 129 | 0.490 |
Why?
|
| Nervous System Diseases | 3 | 2024 | 1660 | 0.480 |
Why?
|
| Cerebral Hemorrhage | 2 | 2023 | 2648 | 0.480 |
Why?
|
| Eyelids | 1 | 2017 | 279 | 0.470 |
Why?
|
| Frontal Lobe | 1 | 2021 | 1410 | 0.470 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2019 | 302 | 0.470 |
Why?
|
| Agraphia | 1 | 2014 | 8 | 0.460 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2021 | 886 | 0.440 |
Why?
|
| Cervical Vertebrae | 2 | 2021 | 974 | 0.420 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2014 | 109 | 0.420 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2014 | 157 | 0.410 |
Why?
|
| Perceptual Disorders | 1 | 2014 | 199 | 0.390 |
Why?
|
| Gout | 1 | 2018 | 620 | 0.370 |
Why?
|
| Encephalitis | 3 | 2022 | 441 | 0.360 |
Why?
|
| Medical Records | 1 | 2014 | 1409 | 0.310 |
Why?
|
| Parietal Lobe | 1 | 2014 | 858 | 0.310 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 712 | 0.310 |
Why?
|
| Ischemia | 1 | 2017 | 1909 | 0.290 |
Why?
|
| Humans | 58 | 2024 | 765968 | 0.290 |
Why?
|
| Antioxidants | 1 | 2016 | 1670 | 0.290 |
Why?
|
| Spinal Fractures | 1 | 2014 | 703 | 0.290 |
Why?
|
| Diagnosis, Differential | 5 | 2024 | 12976 | 0.290 |
Why?
|
| Temporal Lobe | 2 | 2016 | 1714 | 0.280 |
Why?
|
| Publishing | 1 | 2014 | 835 | 0.280 |
Why?
|
| Heparin | 1 | 2014 | 1630 | 0.270 |
Why?
|
| Seizures | 2 | 2017 | 3000 | 0.260 |
Why?
|
| Cephalosporins | 2 | 2019 | 200 | 0.260 |
Why?
|
| Stroke | 3 | 2024 | 9747 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2023 | 36532 | 0.260 |
Why?
|
| Teaching Rounds | 2 | 2021 | 280 | 0.250 |
Why?
|
| Middle Aged | 27 | 2024 | 223009 | 0.250 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2975 | 0.230 |
Why?
|
| Oxidative Stress | 1 | 2016 | 3141 | 0.230 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 2080 | 0.230 |
Why?
|
| Hippocampus | 1 | 2017 | 3775 | 0.220 |
Why?
|
| Susac Syndrome | 1 | 2023 | 22 | 0.210 |
Why?
|
| Telencephalon | 1 | 2023 | 142 | 0.200 |
Why?
|
| Retinal Artery Occlusion | 1 | 2023 | 82 | 0.200 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2022 | 40 | 0.190 |
Why?
|
| Parkinson Disease | 1 | 2016 | 2895 | 0.190 |
Why?
|
| Female | 28 | 2024 | 396112 | 0.180 |
Why?
|
| Uric Acid | 2 | 2018 | 809 | 0.180 |
Why?
|
| Putamen | 1 | 2022 | 289 | 0.180 |
Why?
|
| Meningoencephalitis | 1 | 2021 | 82 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 7478 | 0.180 |
Why?
|
| Male | 24 | 2024 | 363698 | 0.170 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 104 | 0.170 |
Why?
|
| Headache | 2 | 2021 | 1259 | 0.170 |
Why?
|
| Neurologic Examination | 2 | 2021 | 912 | 0.170 |
Why?
|
| Neoplasms | 3 | 2024 | 22340 | 0.170 |
Why?
|
| Mesencephalon | 1 | 2022 | 338 | 0.170 |
Why?
|
| Craniotomy | 1 | 2023 | 730 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 3733 | 0.160 |
Why?
|
| Adult | 17 | 2024 | 223044 | 0.160 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 582 | 0.160 |
Why?
|
| Encephalomalacia | 1 | 2018 | 18 | 0.150 |
Why?
|
| Gadolinium | 1 | 2023 | 965 | 0.150 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 527 | 0.150 |
Why?
|
| Opportunistic Infections | 1 | 2021 | 376 | 0.140 |
Why?
|
| Brain Stem | 1 | 2023 | 853 | 0.140 |
Why?
|
| Contrast Media | 2 | 2023 | 5329 | 0.140 |
Why?
|
| Spine | 2 | 2021 | 1128 | 0.140 |
Why?
|
| Young Adult | 9 | 2024 | 59889 | 0.140 |
Why?
|
| Optic Nerve Diseases | 1 | 2020 | 343 | 0.140 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2017 | 58 | 0.140 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2022 | 550 | 0.130 |
Why?
|
| Brain | 6 | 2023 | 27171 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2022 | 2113 | 0.130 |
Why?
|
| Cerebellum | 1 | 2023 | 1518 | 0.130 |
Why?
|
| Flavivirus | 1 | 2015 | 23 | 0.130 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2015 | 45 | 0.120 |
Why?
|
| Aged | 12 | 2024 | 171117 | 0.120 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2015 | 48 | 0.120 |
Why?
|
| Hashimoto Disease | 1 | 2016 | 110 | 0.120 |
Why?
|
| Myelin Sheath | 1 | 2019 | 652 | 0.120 |
Why?
|
| Rheumatology | 1 | 2021 | 602 | 0.120 |
Why?
|
| Vaccination | 3 | 2022 | 3426 | 0.120 |
Why?
|
| Metronidazole | 1 | 2016 | 236 | 0.110 |
Why?
|
| Pituitary Gland | 1 | 2017 | 631 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2021 | 1194 | 0.110 |
Why?
|
| Infertility | 1 | 2021 | 654 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2880 | 0.110 |
Why?
|
| Treatment Outcome | 6 | 2024 | 65188 | 0.110 |
Why?
|
| Vaccines | 1 | 2022 | 841 | 0.110 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2014 | 172 | 0.110 |
Why?
|
| Recurrence | 2 | 2023 | 8501 | 0.110 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2014 | 49 | 0.110 |
Why?
|
| Phlebography | 1 | 2014 | 328 | 0.100 |
Why?
|
| Ataxia | 1 | 2015 | 307 | 0.100 |
Why?
|
| Penicillins | 1 | 2016 | 404 | 0.100 |
Why?
|
| Writing | 1 | 2014 | 199 | 0.100 |
Why?
|
| Thymus Neoplasms | 1 | 2015 | 270 | 0.100 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 353 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2024 | 81514 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2024 | 4209 | 0.090 |
Why?
|
| Thiazoles | 1 | 2018 | 1529 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2018 | 841 | 0.090 |
Why?
|
| Space Perception | 1 | 2014 | 469 | 0.090 |
Why?
|
| Medicaid | 1 | 2024 | 2833 | 0.090 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2014 | 274 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2016 | 635 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2021 | 2778 | 0.080 |
Why?
|
| Biopsy | 1 | 2021 | 6763 | 0.080 |
Why?
|
| Comorbidity | 1 | 2024 | 10563 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2021 | 3956 | 0.080 |
Why?
|
| Disease Progression | 4 | 2024 | 13632 | 0.080 |
Why?
|
| Psychotic Disorders | 1 | 2024 | 3270 | 0.080 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 2418 | 0.080 |
Why?
|
| Oligopeptides | 1 | 2014 | 1192 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 1275 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2016 | 1181 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2023 | 9347 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2014 | 1472 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2014 | 2243 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2015 | 1263 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2024 | 22223 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 2674 | 0.060 |
Why?
|
| Incidence | 1 | 2024 | 21480 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 5767 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2798 | 0.060 |
Why?
|
| Substantia Innominata | 1 | 2023 | 23 | 0.050 |
Why?
|
| Migraine Disorders | 1 | 2016 | 1732 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2018 | 3459 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14652 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26318 | 0.050 |
Why?
|
| Proteins | 1 | 2016 | 5995 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2022 | 198 | 0.050 |
Why?
|
| Epilepsy | 1 | 2016 | 3320 | 0.040 |
Why?
|
| Adolescent | 3 | 2024 | 88835 | 0.040 |
Why?
|
| Dendrites | 1 | 2023 | 469 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8730 | 0.040 |
Why?
|
| United States | 3 | 2024 | 72903 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3211 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2023 | 1085 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2020 | 567 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 30260 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9071 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2021 | 893 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2024 | 1078 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2024 | 1820 | 0.030 |
Why?
|
| Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2014 | 5197 | 0.030 |
Why?
|
| Fatigue | 1 | 2023 | 1549 | 0.030 |
Why?
|
| New Hampshire | 1 | 2015 | 174 | 0.030 |
Why?
|
| Ixodes | 1 | 2015 | 41 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1354 | 0.030 |
Why?
|
| Acyclovir | 1 | 2015 | 267 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 59489 | 0.030 |
Why?
|
| Nimodipine | 1 | 2014 | 56 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 6069 | 0.030 |
Why?
|
| Piracetam | 1 | 2014 | 88 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2022 | 6273 | 0.030 |
Why?
|
| Meningitis, Bacterial | 1 | 2015 | 222 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2016 | 549 | 0.030 |
Why?
|
| Child | 1 | 2021 | 80564 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2014 | 159 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 6547 | 0.030 |
Why?
|
| Polyneuropathies | 1 | 2014 | 139 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 1462 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2657 | 0.020 |
Why?
|
| Nurses | 1 | 2021 | 2505 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13648 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20659 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2024 | 3076 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3202 | 0.020 |
Why?
|
| Radiography | 1 | 2021 | 6919 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2018 | 1022 | 0.020 |
Why?
|
| Seasons | 1 | 2015 | 1524 | 0.020 |
Why?
|
| Stem Cells | 1 | 2022 | 3540 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 3475 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 2024 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 12768 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3000 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 2033 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2014 | 1921 | 0.010 |
Why?
|
| Disease Management | 1 | 2014 | 2535 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3050 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8875 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 74840 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10850 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 41649 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 39193 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24282 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 30198 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 54802 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15842 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 29922 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 168764 | 0.000 |
Why?
|